• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈低级别上皮内瘤变组织中 HPV L1 衣壳蛋白和 p16 蛋白的免疫组化分析。

Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.

机构信息

School of Health Sciences, Faculty of Medicine, Gunma University, Maebashi, Gunma, Japan.

出版信息

Pathol Res Pract. 2010 Dec 15;206(12):816-20. doi: 10.1016/j.prp.2010.09.005. Epub 2010 Oct 20.

DOI:10.1016/j.prp.2010.09.005
PMID:20965668
Abstract

Human papillomavirus (HPV) L1 capsid protein (L1) is associated with the productive phase of HPV infection. However, the expression of L1 and its relationship to p16 expression, a surrogate marker for HPV infection, are unknown. We examined the relationship between L1 and p16 expression in cervical intraepithelial neoplasia. Tissues were divided into four categories: regressive lesions (n=48), progressive lesions (n=40), and randomly selected CIN1-2 (n=67) and CIN3 (n=44). P16 positivity in the progression cases was significantly higher than that in the regression cases, and p16 positivity in the CIN3 cases was significantly higher than that in any other categories. L1 positivity was not significant between each category. The staining pattern was divided into the following four groups: L1-/p16-, L1+/p16-, L1+/p16+, L1-/p16+. The L1-/p16- pattern was significantly associated with the regression nature in CIN1-2. Some CIN3 cases showing a feature of L1+/p16+, which are still HPV-productive, are likely to exist. The combination of both L1 and p16 may be useful in the evaluation of the progression risk of low-grade cervical dysplasia.

摘要

人乳头瘤病毒(HPV)L1 衣壳蛋白(L1)与 HPV 感染的增殖期相关。然而,L1 的表达及其与 p16 表达的关系,p16 是 HPV 感染的替代标志物,尚不清楚。我们研究了 L1 与宫颈上皮内瘤变(CIN)中 p16 表达的关系。组织分为四类:退行性病变(n=48)、进行性病变(n=40),以及随机选择的 CIN1-2(n=67)和 CIN3(n=44)。进展病例的 p16 阳性率明显高于退行性病变,CIN3 病例的 p16 阳性率明显高于其他任何类别。每个类别之间 L1 阳性率没有显著差异。染色模式分为以下四种:L1-/p16-、L1+/p16-、L1+/p16+、L1-/p16+。L1-/p16-模式与 CIN1-2 的退行性特征显著相关。一些表现为 L1+/p16+特征的 CIN3 病例仍具有 HPV 增殖性,可能存在。同时检测 L1 和 p16 可能有助于评估低级别宫颈上皮内瘤变的进展风险。

相似文献

1
Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.宫颈低级别上皮内瘤变组织中 HPV L1 衣壳蛋白和 p16 蛋白的免疫组化分析。
Pathol Res Pract. 2010 Dec 15;206(12):816-20. doi: 10.1016/j.prp.2010.09.005. Epub 2010 Oct 20.
2
p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.p16 抑癌基因和人乳头瘤病毒L1免疫组化有助于评估子宫颈低度发育异常病变的行为。
Am J Surg Pathol. 2008 Nov;32(11):1715-20. doi: 10.1097/PAS.0b013e3181709fbf.
3
HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.CIN1中HPV L1和P16的表达以预测未来的CIN2
Int J Gynecol Pathol. 2017 May;36(3):281-288. doi: 10.1097/PGP.0000000000000326.
4
Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.宫颈鳞状上皮内病变中p16和人乳头瘤病毒L1衣壳蛋白的免疫化学评估
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):1118-24.
5
Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.人乳头瘤病毒 L1 衣壳蛋白和 HPV 检测在持续 ASCUS/LSIL 宫颈细胞学患者中作为宫颈上皮内瘤变 2+的预后标志物的效用。
Int J Med Sci. 2019 Aug 6;16(8):1096-1101. doi: 10.7150/ijms.31163. eCollection 2019.
6
Characterization of cervical biopsies of women with HIV and HPV co-infection using p16, ki-67 and HPV E4 immunohistochemistry and DNA methylation.采用 p16、ki-67 和 HPV E4 免疫组化及 DNA 甲基化技术对 HIV 和 HPV 合并感染女性的宫颈活检组织进行特征描述。
Mod Pathol. 2020 Oct;33(10):1968-1978. doi: 10.1038/s41379-020-0528-x. Epub 2020 Apr 6.
7
Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.通过将新型分子生物标志物PanHPVE4与P16INK4a相结合来研究与高危型人乳头瘤病毒相关的CIN1和CIN2的诊断问题。
Am J Surg Pathol. 2015 Nov;39(11):1518-1528. doi: 10.1097/PAS.0000000000000498.
8
Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.在低级别宫颈上皮内瘤变中 L1、p16 和 Ki-67 蛋白及 HPV DNA 的诊断意义。
Int J Gynecol Pathol. 2011 Nov;30(6):597-604. doi: 10.1097/PGP.0b013e31821ac4fd.
9
Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.CK7、人乳头瘤病毒L1及挖空细胞对宫颈低度鳞状上皮内病变患者的临床意义:一项回顾性分析
Hum Pathol. 2017 Jul;65:194-200. doi: 10.1016/j.humpath.2017.05.017. Epub 2017 May 26.
10
Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.使用p16免疫组化对形态学上的宫颈上皮内瘤变2级进行分类:不明确染色模式与HPV亚型及临床结局的相关性
Hum Pathol. 2017 Aug;66:144-151. doi: 10.1016/j.humpath.2017.06.014. Epub 2017 Jul 11.

引用本文的文献

1
L1 Capsid Protein Expression in HPV-Positive Barrett Metaplasia-Dysplasia-Adenocarcinoma Lesions.人乳头瘤病毒阳性的巴雷特化生-发育异常-腺癌病变中L1衣壳蛋白的表达
Clin Transl Gastroenterol. 2025 May 12;16(7):e00853. doi: 10.14309/ctg.0000000000000853. eCollection 2025 Jul 1.
2
Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.人乳头瘤病毒 L1 衣壳蛋白和 HPV 检测在持续 ASCUS/LSIL 宫颈细胞学患者中作为宫颈上皮内瘤变 2+的预后标志物的效用。
Int J Med Sci. 2019 Aug 6;16(8):1096-1101. doi: 10.7150/ijms.31163. eCollection 2019.
3
Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
免疫组织化学检测鳞状上皮内病变中人乳头瘤病毒衣壳蛋白 L1 和 L2:在诊断和管理中的潜在应用。
Mod Pathol. 2013 Feb;26(2):268-74. doi: 10.1038/modpathol.2012.156. Epub 2012 Sep 21.
4
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.人乳头瘤病毒与宫颈癌:改善预防措施的生物标志物。
Future Microbiol. 2011 Sep;6(9):1083-98. doi: 10.2217/fmb.11.87.